About Boca Biolistics
Boca Biolistics is a Healthcare company based in Pompano Beach (United States) founded in 2005. Oncology drug clinical development services are provided as a CRO. Boca Biolistics has raised $25 million across 1 funding round from investors including Clairvest. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Aster Insights, OnCusp and CancerVax; 3 of its 3 listed competitors have raised funding.
Company details
Boca Biolistics was established in 2005 in Pompano Beach, United States, as a contract research organization. Clinical development services for oncology drugs are delivered, encompassing trial management and regulatory support within the biopharmaceutical sector. Operations are centered on supporting pharmaceutical clients through specialized expertise in cancer therapeutics. The companys domain, bocabio.com, facilitates access to these services for global partners.
- Headquarters Pompano Beach, United States
- SectorsHealthcare
- Website bocabio.com
- Social LinkedIn X Facebook
- Total Equity Funding$25M (USD)
in 1 rounds
- Latest Funding Round$25M (USD), Series B
Feb 2023
- Investors
Funding Insights of Boca Biolistics
Boca Biolistics has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series B round of $25 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25M
- Total Rounds 1
- Last Round Series B — $25M
- First Round $25M
(Feb 2023)
- Investors Count 1
All 1 funding rounds of Boca Biolistics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | $25M | Series B | – | Clairvest | – |
1 investors in total: 1 institutional.
Investors in Boca Biolistics
Boca Biolistics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Clairvest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment management firm | 1987 | clairvest.com | Toronto, Canada |
Investor details for Boca Biolistics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Boca Biolistics
9 people are tracked at Boca Biolistics (6 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Michael Morris | Chief Operating Officer | Leadership |
Frederick Kiechle | Medical Director | Leadership |
Val Adia | Chief Executive Officer | Leadership |
Chelsea Bouvier | Vice President Of Sales | Leadership |
Joe Burick | Chief Financial Officer | Leadership |
Brynn Zinsman | Director Of Business Development | Leadership |
Marcin Kopczak | Business Development Representative | Team |
Isha Parsana | Business Development Manager | Team |
Rachel Rich | Business Development Representative | Team |
Complete people profiles for Boca Biolistics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Boca Biolistics
2 dated milestones of Boca Biolistics across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Boca Biolistics is founded.
- Funding First funding round of $25.0M.
Competitors of Boca Biolistics
Boca Biolistics has 3 listed competitors in our database, 3 of them funded. They include Aster Insights, OnCusp and CancerVax.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asterinsights.com | 2006 | Tampa, United States | $75M | 115 | Contract-based oncology clinical trial services are provided by Aster Insights. | |
| oncusptx.com | 2021 | New York, United States | $100M | CRO offering clinical development services for oncology drugs | ||
| cancervax.com | 1998 | Carlsbad, United States | $55M | Cancer vaccine research and development is conducted by CancerVax. |
Detailed competitors of Boca Biolistics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Boca Biolistics
The website of Boca Biolistics (bocabio.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 12.2% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Boca Biolistics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Boca Biolistics
Complete news archive for Boca Biolistics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boca Biolistics
Boca Biolistics was founded in 2005 and raised its 1st funding round 18 years after it was founded.
Boca Biolistics is headquartered in Pompano Beach, United States. It is registered at Pompano Beach, Florida, United States.
Boca Biolistics is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Series B of $25M, raised on Feb 2023.
Boca Biolistics was established in 2005 in Pompano Beach, United States, as a contract research organization. Clinical development services for oncology drugs are delivered, encompassing trial management and regulatory support within the biopharmaceutical sector. Operations are centered on supporting pharmaceutical clients through specialized expertise in cancer therapeutics. The companys domain, bocabio.com, facilitates access to these services for global partners.
Boca Biolistics's top competitors include CancerVax, OnCusp and Aster Insights.
Boca Biolistics has 1 investor. Key investors include Clairvest.